Angiotensin converting enzyme, angiotensin II, and arrhythmia

血管紧张素转换酶、血管紧张素 II 和心律失常

基本信息

  • 批准号:
    7645746
  • 负责人:
  • 金额:
    $ 38.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-08-01 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Activation of the renin-angiotensin system (RAS) is associated with increased cardiovascular death. A critical component of this system is angiotensin converting enzyme (ACE), which cleaves angiotensin I to angiotensin II (Angll). In humans, increased Angll levels are associated with an increased ventricular arrhythmic risk. Nevertheless, the reasons for the increased risk are unclear. One critical effect of RAS activation is Angll-induced oxidative stress mediated, in part, by increased NADPH oxidase activity. We hypothesized that oxidative stress caused by Angll induced cardiac arrhythmias. To investigate this, we developed a cardiac-restricted ACE overexpression mouse (ACE 8/8) that showed an increased risk of sudden death in the absence of heart failure or structural heart disease. Intracardiac recordings demonstrate poor conduction and various forms of AV nodal block. Ventricular pacing readily induced ventricular tachycardia. This phenotype is associated with reductions in cardiac sodium channels. We have developed preliminary data that Angll-mediated oxidative stress activates the transcription factor NFkB resulting in downregulation of the cardiac sodium channel. In this proposal, we hypothesize that increased Angll leads to oxidative stress which in-turn alters sodium channel transcription through NFkB activation. An altered ion channel level contributes to the ACE 8/8 mouse arrhythmic phenotype. This proposal is a plan to dissect the steps in this putative cascade and to identify which are proximate causes, which are upstream events, and which are associated but not causative steps. In each aim, we will establish to what extent measures of the sodium channel, NFkB activation, oxidative stress, and arrhythmic risk are altered by the disruptions in the proposed signaling cascade. Specific Objectives. Specific aim 1: To establish to what extent Angll-mediated signaling is responsible for the sodium channel regulation in our ACE overexpression model. Specific aim 2: To establish to what extent NADPH oxidase activation is responsible for the sodium channel regulation in our ACE overexpression model. Specific aim 3: To establish to what extent increased NFkB activation is responsible for the sodium channel regulation in our ACE overexpression model. This application presents a novel hypothesis about why RAS activation causes arrhythmias, contributing to atrial fibrillation (AF) and heart failure (HF)-associated sudden death.
描述(由申请方提供):肾素-血管紧张素系统(RAS)激活与心血管死亡增加相关。该系统的一个重要组成部分是血管紧张素转换酶(ACE),它将血管紧张素I切割为血管紧张素II(AngII)。在人类中,增加的AngII水平与增加的心室肥大风险相关。然而,风险增加的原因尚不清楚。RAS激活的一个关键作用是AngII诱导的氧化应激,其部分由增加的NADPH氧化酶活性介导。我们假设由AngII引起的氧化应激诱导心律失常。为了研究这一点,我们开发了一种心脏限制性ACE过表达小鼠(ACE 8/8),该小鼠在没有心力衰竭或结构性心脏病的情况下显示猝死风险增加。心内记录显示传导不良和各种形式的房室结传导阻滞。心室起搏易诱发室性心动过速。这种表型与心脏钠通道的减少有关。我们已经开发了AngII介导的氧化应激激活转录因子NF κ B导致心脏钠通道下调的初步数据。在该提议中,我们假设增加的AngII导致氧化应激,其进而通过NF κ B活化改变钠通道转录。改变的离子通道水平有助于ACE 8/8小鼠的细胞表型。本提案是一项计划,旨在剖析这一假定级联中的步骤,并确定哪些是近因,哪些是上游事件,哪些是相关但不是因果步骤。在每一个目标中,我们将建立在何种程度上的措施,钠通道,NF κ B激活,氧化应激,并在拟议的信号级联中断改变中毒风险。具体目标。具体目标1:确定AngII介导的信号传导在何种程度上负责我们的ACE过表达模型中的钠通道调节。具体目标2:在我们的ACE过表达模型中,确定NADPH氧化酶激活在多大程度上负责钠通道调节。具体目标3:在我们的ACE过表达模型中,确定NFkB激活增加在多大程度上负责钠通道调节。本申请提出了一种关于RAS激活导致心律失常的新假设,导致房颤(AF)和心力衰竭(HF)相关猝死。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAMUEL C DUDLEY其他文献

SAMUEL C DUDLEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAMUEL C DUDLEY', 18)}}的其他基金

Resolution of inflammation and atrial fibrillation
炎症和心房颤动的解决
  • 批准号:
    10679718
  • 财政年份:
    2023
  • 资助金额:
    $ 38.86万
  • 项目类别:
Magnesium, mitochondria, and diastolic dysfunction
镁、线粒体和舒张功能障碍
  • 批准号:
    10705354
  • 财政年份:
    2022
  • 资助金额:
    $ 38.86万
  • 项目类别:
Unfolded Protein Response and Arrhythmias
未折叠的蛋白质反应和心律失常
  • 批准号:
    9977253
  • 财政年份:
    2017
  • 资助金额:
    $ 38.86万
  • 项目类别:
A blood test to predict sudden death risk
预测猝死风险的血液测试
  • 批准号:
    8392935
  • 财政年份:
    2012
  • 资助金额:
    $ 38.86万
  • 项目类别:
Na+ channel mRNA splicing in heart failure
心力衰竭中的 Na 通道 mRNA 剪接
  • 批准号:
    8318101
  • 财政年份:
    2011
  • 资助金额:
    $ 38.86万
  • 项目类别:
Na+ channel mRNA splicing in heart failure
心力衰竭中的 Na 通道 mRNA 剪接
  • 批准号:
    8676905
  • 财政年份:
    2011
  • 资助金额:
    $ 38.86万
  • 项目类别:
Na+ channel mRNA splicing in heart failure
心力衰竭中的 Na 通道 mRNA 剪接
  • 批准号:
    8722085
  • 财政年份:
    2011
  • 资助金额:
    $ 38.86万
  • 项目类别:
Metabolic Regulation of Sodium Channels
钠通道的代谢调节
  • 批准号:
    8186151
  • 财政年份:
    2011
  • 资助金额:
    $ 38.86万
  • 项目类别:
Metabolic Regulation of Sodium Channels
钠通道的代谢调节
  • 批准号:
    8733197
  • 财政年份:
    2011
  • 资助金额:
    $ 38.86万
  • 项目类别:
Metabolic Regulation of Sodium Channels
钠通道的代谢调节
  • 批准号:
    8306025
  • 财政年份:
    2011
  • 资助金额:
    $ 38.86万
  • 项目类别:

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.86万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 38.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 38.86万
  • 项目类别:
    Continuing Grant
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 38.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 38.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 38.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 38.86万
  • 项目类别:
    Studentship
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 38.86万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 38.86万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 38.86万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了